Predictive Oncology launches private placements for cash and crypto, shifts to ATH token treasury

Axe Compute Inc.

Cash offering: ~55.2M shares at $0.7751/share plus pre-funded warrants for 11.5M shares. Cryptocurrency offering: pre-funded warrants for ~223.6M shares with investors tendering ATH tokens.
Company adopts digital asset treasury strategy focused on ATH; proceeds from offerings to buy ATH and generate yield via staking/lending, managed by DNA Holdings.
Board changes: Nancy Chung-Welch resigns effective closing; Shawn Matthews (CEO of DNA Holdings) appointed to Board as Class II director.
Bylaw amendment caps Board size at seven directors; reverse stock split 1:15 approved by stockholders, effective Sept 30, 2025 (prices pre-split).

item 1.01item 3.02item 5.02item 5.03item 7.01item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.